Carbidopa_and_Levodopa: profile and news

IMPAX Settles Patent Suit and Signs Marketing and Promotion ...  Jan 19, 2006
...target market for Carbatrol of approximately 8,300 neurologists in the US overlaps with the Company's target market for Vadova(TM) (carbidopa and levodopa). ... - Genetic Engineering News,

Twice As Many Parkinson's Disease Patients Prefer Orally ...  Feb 14, 2005
About Parcopa Recently approved by the FDA, Parcopa (carbidopa-levodopa orally disintegrating tablets) is a combination of carbidopa and levodopa in tablets ... - PR Newswire (press release)